Melatonin. Perspectives in Laboratory Medicine and Clinical Research

References

• Lerner A. B., Case J. D., Takahashi Y., Lee T. H., More W. Isolation of melatonin, the pineal factor that lightens melanocytes. J. Am. Chem. Soc 1958; 80: 2587
   Web of Science ®Google Scholar
• Vesalius A. De Humani Corporis Fabrica. Libri Septem2nd ed. Basiliae 1555
   Google Scholar
• De Homine Descartes R. Figuris et Latinitale donatus a F. Schuyl, Lugduni Bataverum. 1662
   Google Scholar
• Waldhauser F., Weiszenbach G., Frisch H., Zeitlhuber V., Waldhauser M., Wurtman R. H. Fall in nocturnal serum melatonin during prepuberty and pubescence. Lancet 1984; 1: 362
   PubMed Web of Science ®Google Scholar
• Penny R. Episodic secretion of melatonin in pre- and postpubertal girls and boys. J. Clin. Endocrinol. Metab. 1985; 60: 751
   PubMed Web of Science ®Google Scholar
• Wurtman R. J., Altschule M. D., Holmgren U. Effects of pinealectomy and of a bovine pineal extract in rats. Am. J. Physiol. 1959; 197: 108
   PubMedGoogle Scholar
• Reiter R. J. The pineal and its hormones in the control of reproduction of mammals. Endocrinol. Rev. 1980; 1: 109
   PubMedGoogle Scholar
• De Frenzo R. A., Roth W. D. Evidence for the existence of a pineal-adrenal and pineal-thyroida’ axis. Acta. Endocrinol. 1972; 70: 31
   Google Scholar
• Relkin R. Effects of pinealectomy and constant light and darkness on thyrotropin levels in the pituitary and plasma of the rat. Neuroendocrinology 1972; 10: 46
   PubMed Web of Science ®Google Scholar
• Vriend J. Testing the TRH hypothesis of pineal function. Med. Hypoth. 1978; 4: 376
   PubMed Web of Science ®Google Scholar
• Ogle T. F., Kitay J. I. Effects of melatonin and an aqueous pineal extract on adrenal secretion of reduced steroid metabolites in female rats. Neuroendocrinology 1977; 23: 113
   PubMed Web of Science ®Google Scholar
• Ogle T. F., Kitay J. I. In vitro effects of melatonin and serotonin on adrenal steroidogenesis. Proc. Soc. Exp. Biol. Med. 1978; 157: 103
   PubMed Web of Science ®Google Scholar
• Lerner A. B., Case J. D., Heinzelman R. V. Structure of melatonin. J. Am. Ckem. Soc 1959; 81: 6085
   Google Scholar
• Weissbach H., Redfield B. G., Axelrod J. Biosynthesis of melatonin: enzymatic conversion of serotonin to N-acetylserotonin. Biochem. Biophys. Acta 1960; 43: 352
   PubMedGoogle Scholar
• Axelrod J., Weissbach H. Enzymatic O-methylation of N-acetylserotonin to melatonin. Science 1960; 131: 1312
   PubMed Web of Science ®Google Scholar
• Barchas J., Dalcosta F., Spector S. Acute pharmacology of melatonin. Nature (London) 1967; 214: 919
   PubMed Web of Science ®Google Scholar
• Jones R. L., McGeer P. L., Greiner A. C. Metabolism of exogenous melatonin in schizophrenic and non-schizophrenic subjects. Clin. Chim. Acta 1969; 26: 281
   PubMed Web of Science ®Google Scholar
• Tay Anton F., Diaz J. L., Fernandez-Guardiola M. On the effects of melatonin upon human brain: its possible therapeutic implications. Life Sci. 1971; 10: 841
   Google Scholar
• Cramer H., Rudolph J., Consbruch U. On the effects of melatonin on sleep and behaviour in man. Serotonin: New Vistas, Biochemistry and Behavioural and Clinical Studies. Vol. 2, Advances in Biochemical Psychopharmacology, E. Costa, G. L. Gessa, M. Sandler. Raven Press, New York 1974; 187
   Google Scholar
• Birau N. Melatonin in human serum: progress in screening, investigation and clinic. Melatonin: Current Status and Perspectives Vol. 29, Advances in the Biosciences, N. Birau, W. Schloot. Pergamon Press, New York 1981; 297
   Google Scholar
• Carman J. S., Post R. M., Bushell R., Goodwin F. K. Negative effects of melatonin on depression, Am. J. Psychiatr. 1976; 133: 1181
   Google Scholar
• Axelrod J. The pineal gland: a neurochemical transducer. Science 1974; 184: 1341
   PubMed Web of Science ®Google Scholar
• Wetterberg L. Melatonin in humans. Physiological and clinical studies. J. Neural Transm. 1978; 13: 289, (Suppl.)
   Google Scholar
• Arato M., Grof E., Grof P., Laszlo I., Brown G. M. Reproducibility of the overnight melatonin secretion pattern in healthy men. The Pineal Gland: Endocrine Aspects Vol. 53, Advances in the Biosciences, G. M. Brown, S. D. Wainwright. Pergamon Press, New York 1985; 277
   Google Scholar
• Arendt J., Hampton S., English J., Kwasowski P., Marks V. 24-hour profiles of melatonin, Cortisol, insulin, e-peptide and GIP following a meal and subsequent fasting. Clin. Endocrinol. 1982; 16: 89
   PubMed Web of Science ®Google Scholar
• Wetterberg L., Iselius L., Lindsten J. Genetic regulation of melatonin excretion in urine. A preliminary report. Clin. Genet. 1984; 24: 399
   Web of Science ®Google Scholar
• Lewy A., Markey S. P. Analysis of melatonin in human plasma by gas chromatography negative chemical ionisation mass spectrometry. Science 1978; 201: 741
   PubMed Web of Science ®Google Scholar
• Klein D. C., Weller J. L. Indole metabolism in the pineal gland: a circadian rhythm in N-acetyl-transferase. Science 1970; 169: 1093
   PubMed Web of Science ®Google Scholar
• Moore R. Y., Paunier L., Sizonenko P. C. Effect of adrenergic stimulation and blockade of melatonin secretion in the human. Prog. Brain Res. 1979; 52: 517
   PubMedGoogle Scholar
• Moore R. Y., Klein D. C. Visual pathways and the central neural control of a circadian rhythm in pineal serotonin N-acetyltransferase activity. Brain Res. 1974; 71: 17
   PubMed Web of Science ®Google Scholar
• Buda M., Klein D. C. A suspension culture of pinealocytes. Regulation of N-acetyltransferase activity. Endocrinology 1978; 103: 1483
   PubMed Web of Science ®Google Scholar
• Sadun A. A., Schaechter J. D., Smith L. E. H. A retino-hypothalamic pathway in man — light mediation of circadian rhythms. Brain Res. 1984; 302: 371
   PubMed Web of Science ®Google Scholar
• Reppert S. M., Perlow M. J., Klein D. C. Cerebrospinal fluid melatonin. Neurobiology of Cerebrospinal Fluid, J. H. Wood. Plenum Press, New York 1980; 579
   Google Scholar
• Hedlund L., Lischko N. M., Rollag M. D., Niswender G. D. Melatonin: daily cycle in plasma and cerebrospinal fluid of calves. Science 1977; 195: 686
   PubMed Web of Science ®Google Scholar
• Rollag M. D., Morgan R. J., Niswender G. D. Route of melatonin secretion in sheep. Endocrinology 1978; 102: 1
   PubMed Web of Science ®Google Scholar
• Young I. M., Silman R. E. Pineal methoxyindoles in the human. The Pineal Gland, R. J. Reiter. CRC Press, Boca Raton, Fla. 1981; Vol. 3: 189
   Google Scholar
• Cardinali D. P., Lynch H. J., Wurtman R. J. Binding of melatonin to human and rat plasma proteins. Endocrinology 1972; 91: 1213
   PubMed Web of Science ®Google Scholar
• Lane E. A., Moss H. B. Pharmacokinetics of melatonin in man: first pass hepatic metabolism. J. Clin. Endocrinol. Metab. 1985; 61: 1214
   PubMed Web of Science ®Google Scholar
• Hirata F., Hayaishi O., Tokuyama T., Senoh S. In vitro and in vivo formation of two new metabolites of melatonin. J. Biol. Chem. 1974; 249: 1311
   PubMed Web of Science ®Google Scholar
• Kopp N., Claustrat B., Tappaz M. Evidence for the presence of melatonin in human brain. Neurosci. Lett. 1980; 19: 237
   PubMed Web of Science ®Google Scholar
• Niles L. P., Wong Y. W., Mishra R. K., Brown G. M. Melatonin receptors in brain. Eur. J. Pharmacol. 1979; 55: 219
   PubMed Web of Science ®Google Scholar
• Glass J. D., Lynch G. R. Evidence for a brain site of melatonin action in the white footed mouse Peromyscus Leucopsus. Neuroendocrinology. 1982; 34: 1
   PubMed Web of Science ®Google Scholar
• Lerner A. B., Case J. D. Melatonin. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1960; 19: 590
   Google Scholar
• Moskowitz M. A., Wurtman R. J. Pathological states involving the pineal. Clinical Neuroendocrinology, L. Martini, G. M. Besser. Academic Press, New York 1977; 503
   Google Scholar
• Arendt J., Borbely A. A., Franey C., Wright J. The effects of chronic small doses of melatonin given in the late afternoon on fatigue in man: a preliminary study. Neurosci. Lett. 1984; 45: 317
   PubMed Web of Science ®Google Scholar
• Shaw K. M., Stern G. M., Sandler M. Melatonin and Parkinsonism. Lancet 1973; 1: 271
   PubMed Web of Science ®Google Scholar
• Reiter R. J., Black D. E., Johnson L. Y., Rudhern P. K., Vaughan M. K., Waring P. J. Melatonin inhibition of reproduction in the male hamster: its dependency on time of day of administration and on intact and sympathetically innervated pineal gland. Neuroendocrinology 1976; 22: 107
   PubMed Web of Science ®Google Scholar
• Stetson M. H., Tay D. E. Time course and sensitivity of golden hamsters to melatonin injections throughout the day. Biol. Reprod. 1983; 29: 432
   PubMed Web of Science ®Google Scholar
• Vollrath L., Semm P., Gammel G. Sleep induction by intranasal application of melatonin. Melatonin: Current Status and Perspectives, N. Birau, W. Schloot. Pergamon Press, New York 1981
   Google Scholar
• McNair D. M. Anti-anxiety drugs and human performance. Arch. Gen. Psychiatr., 29: 611
   PubMed Web of Science ®Google Scholar
• Lieberman H. R., Garfield G., Waldhauser F., Lynch H. J., Wurtman R. J. Possible behavioural consequences of light induced changes in melatonin availability. Ann. N.Y. Acad. Sci. 1985; 453: 242
   PubMed Web of Science ®Google Scholar
• Arendt J. Melatonin assays in body fluids. J. Neural Transm. 1978; 13: 265, (Suppl.)
   Google Scholar
• Arendt J., Paunier L., Sizonenko P. C. Melatonin radioimmunoassay. J. Clin. Endocrinol. Metab. 1975; 40: 347
   PubMed Web of Science ®Google Scholar
• Levine L., Riceberg L. J. Radioimmunoassay for melatonin. Res. Commun. Chem. Pathol. 1975; 10: 693
   PubMedGoogle Scholar
• Rollag M. D., Niswender G. D. Radioimmunoassay of serum concentrations of melatonin in sheep exposed to different lighting regimes. Endocrinology 1976; 98: 482
   PubMed Web of Science ®Google Scholar
• Pang S. F., Brown G. M., Grota L. J., Rodman R. L. Radioimmunoassay of melatonin in pineal glands, Harderian glands, retinas and sera of rats and chickens. Fed. Proc. Fed. Am. Soc. Exp. Biol. 1976; 35: 691
   Google Scholar
• Goldman M. E., Hamm H., Erickson C. K. Determination of melatonin by high performance liquid chromatography with electrochemical detection. J. Chromatog. 1980; 190: 217
   PubMed Web of Science ®Google Scholar
• Frazer S., Cowen P., Franklin M., Franey C., Arendt J. Direct radioimmunoassay for melatonin in plasma. Clin. Chem. 1983; 29: 396
   PubMed Web of Science ®Google Scholar
• Miles A., Philbrick D. R. S., Tidmarsh S. F., Shaw D. M. Direct radioimmunoassay of melatonin in saliva. Clin. Chem. 1985; 31: 1412
   PubMed Web of Science ®Google Scholar
• Ferrua B. Estimation of melatonin with an enzyme labelled antibody system. J. Immunoassay 1985; 6: 79
   PubMed Web of Science ®Google Scholar
• Vakkuri O., Lamsa E., Rahkamaa E., Ruotsalainen H., Leppaluoto J. Iodinated melatonin: preparation and characterisation of the molecular structure by mass and HNMR spectroscopy. Anal. Biochem. 1984; 142: 284
   PubMed Web of Science ®Google Scholar
• Tiefenauer L. X. Prevention of bridge binding effects in haptenic immunoassay systems exemplified by an iodinated radioimmunoassay for melatonin. J. Immunol. Meth. 1984; 74: 293
   PubMed Web of Science ®Google Scholar
• Miles A., Philbrick D. R. S., Shaw D. M., Tidmarsh S. F., Pugh A. J. Salivary melatonin estimation in clinical research. Clin. Chem. 1985; 31: 2041
   PubMed Web of Science ®Google Scholar
• Riad-Fahmy D., Read G. F., Walker R. F., Griffiths K. Steroids in saliva for assessing endocrine function. Endocr. Rev. 1982; 3: 367
   PubMed Web of Science ®Google Scholar
• Miles A., Philbrick D. R. S., Thomas D. R., Shaw D. M. The 24-hour profiles of plasma and salivary melatonin in volunteer subjects: basic and clinical implications. Clin. Chim.
   Google Scholar
• Miles A., Thomas D. R., Philbrick D. R. S., Shaw D. M. Longitudinal study of salivary melatonin profiles in healthy males. Clin. Chem.
   Google Scholar
• Thompson C., Isacs G., Miles A. Seasonal Affective Disorder, Phototherapy and Melatonin Levels, British Association for Psychopharmacology, Summer Meeting. Cambridge 1986
   Google Scholar
• Arendt J., Bojkowski C., Franey C., Wright J., Marks V. Immunoassay of 6-hydroxymelatonin sulphate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J. Clin. Endocrinol. Metab. 1985; 60: 1166
   PubMed Web of Science ®Google Scholar
• Markey S. P., Higa S., Shih M., Danforth D. N., Tamarkin L. The correlation between human plasma melatonin levels and urinary 6-hydroxymelatonin excretion. Clin. Chim. Acta 1985; 150: 221
   PubMed Web of Science ®Google Scholar
• Tetsuo M., Markey S. P., Kopin I. J. Measurement of 6-hydroxymelatonin in human urine and its diurnal variations. Life Sci. 1980; 27: 105
   PubMed Web of Science ®Google Scholar
• Young I. M., Leone R. M., Silman R. E. The mass spectrometric analysis of the urinary metabolites of melatonin and its deuterated analogues confirming their identity as N-acetyl secretonin and 6-hydroxymelatonin. Biomed. Mass. Spectrom. 1985; 12: 319
   PubMedGoogle Scholar
• Johansson G. E. K., Ho A. K., Chik C. L., Brown G. M. Interference in melatonin radioimmunoassay by hepar in preparations. The Pineal Gland: Endocrine Aspects, G. M. Brown, S. D. Wainwright. Advances in the Biosciences, Pergamon Press, New York 1985; Vol. 53: 47
   Google Scholar
• Arendt J., personal communication
   Google Scholar
• Yalow S., Berson A. Immunological assays. Principles of Competitive Protein Binding Assays, W. Odell, F. Daughady. J. B. Lippincott, Philadelphia 1971; 377
   Google Scholar
• Grota L. J., Holloway W. R., Brown G. M. Twenty-four-hour rhythm of hypothalamic melatonin immunofluorescence correlates with serum and retinal melatonin rhythms. Neuroendocrinology 1982; 34: 363
   PubMed Web of Science ®Google Scholar
• Cohen H. N., Hay D., Annesley T. N., Beastall G. H., Wallace A. N., Sooner S., Thompson J. A., Eastwold P., Klee G. C. Serum immunoreactive melatonin in boys with delayed puberty. Clin. Endocrinol. 1982; 17: 517
   PubMed Web of Science ®Google Scholar
• Lissoni P., Mauri R., Resentini M., Morabito F., Djemal S., Fraschini F. Melatonin rhythm in some idiopathic hypothalamic-hypophyseal diseases. The Pineal Gland: Endocrine Aspects, G. M. Brown, S. D. Wainwright. Advances in the Biosciences, Pergamon Press, New York 1985; Vol. 59: 307
   Google Scholar
• Rabson S. M., Mendenhall E. N. Pineal gland hypertrophy and diabetes mellitus. Am. J. Clin. Pathol. 1956; 26: 283
   PubMed Web of Science ®Google Scholar
• Barnes N. D., Palumbo D. J., Hayles A. B., Folgar H. Mendalhall's syndrome. Diabetologia 1974; 10: 285
   PubMedGoogle Scholar
• West R. J., Lloyd J. K., Turner W. M. L. Mendenhall's syndrome a series of case reports. Arch. Dis. Child. 1975; 50: 703
   PubMed Web of Science ®Google Scholar
• Atkins T. W., Bailey C. J., Matty A. J. The effect of melatonin on insulin secretion in the rat and mouse. J. Endocrinol. 1973; 58: 17, (Abstr.)
   Web of Science ®Google Scholar
• Smyth G. A., Lazarus L. Suppression of human growth hormone secretion by melatonic and cyproheptadine. J. Clin. Invest. 1974; 54: 116
   PubMed Web of Science ®Google Scholar
• Rodin A. E. The growth and spread of Walker 256 carcinoma in pinealectomized rats. Cancer Res. 1963; 23: 1545
   PubMed Web of Science ®Google Scholar
• Das Gupta T. K., Terz J. Influence of pineal gland on the growth and spread of melanoma in the hamster. Cancer Res. 1967; 27: 1306
   PubMed Web of Science ®Google Scholar
• Lapin V. The pineal gland and neoplasia. Lancet 1975; 1: 341
   PubMedGoogle Scholar
• El-Domeiri A. A. H., Das Gupta T. K. Reversal by melatonin of the effect of pinealectomy on tumour growth. Cancer Res. 1973; 33: 2830
   PubMed Web of Science ®Google Scholar
• Lapin V., Ebels J. Effect of some low molecular weight pineal fractions and melatonin on different tumour in rats and mice. Oncology 1976; 33: 110
   PubMed Web of Science ®Google Scholar
• Dilman V. M., Anisimov V. N., Ostroumova M. N., Morosov V. G., Khavinson V., Azarova M. A. Study of the anti-tumour effect of polypeptial pineal extract. Oncology 1979; 36: 274
   PubMedGoogle Scholar
• Banerjee S., Margulis L. Mitotic arrest by melatonin. Exp. Cell Res. 1973; 78: 314
   PubMed Web of Science ®Google Scholar
• Smyth G. A., Stuart M. C., Lazarus L. Stimulation and suppression of somatomedin activity by serotonin and melatonin. Experentia 1974; 30: 1356
   PubMedGoogle Scholar
• Bartsch H., Bartsch C. Effect of melatonin on experimental tumours under different photoperiods and times of administration. J. Neural Transm. 1981; 52: 269
   PubMed Web of Science ®Google Scholar
• Rodin A. E., Overall J. Statistical relationships of weight of the human pineal gland to age and malignancy. Cancer 1962; 20: 1203
   Google Scholar
• Tapp E., Blumfield M. The weight of the pineal gland in malignancy. Br. J. Cancer 1970; 24: 67
   PubMed Web of Science ®Google Scholar
• Tapp E. The human pineal gland in malignancy. J. Neural Transm. 1980; 48: 119
   PubMed Web of Science ®Google Scholar
• Raikhlin N. T., Kvetnoy I. M., Tyurin E. S. Melatonin in the blood serum of oncological patients. Klin. Med. (Mosk.) 1980; 58: 77
   PubMedGoogle Scholar
• Bartsch C., Bartsch J., Jain A. K., Laumas K. R., Wetterberg L. Urinary melatonin levels in human breast cancer patients. J. Neurol. Transm. 1981; 52: 281
   PubMed Web of Science ®Google Scholar
• Tamarkin L., Danforth D., Lichter A. Decreased nocturnal plasma melatonin peak in patients with oestrogen receptor positive breast cancer. Science 1982; 216: 1003
   PubMed Web of Science ®Google Scholar
• Lissoni P., Viviane S., Bajetta E., Buzzoni R., Barreca A., Mauri R., Resentini M., Morabito F., Esposti D., Esposti G., Fraschini F. A clinical study of the pineal gland activity in oncological patients. Cancer 1986; 57: 837
   PubMed Web of Science ®Google Scholar
• Lapin V., Frowein A. Effect of growing tumours on pineal melatonin levels in male rats. J. Neural Transm. 1981; 52: 123
   PubMed Web of Science ®Google Scholar
• Relkin R. The pineal and human disease. Annual Research Reviews: the Pineal, R. Relkin. Lundsdale House, LancasterEngland 1976; 76
   Google Scholar
• Bartsch C., Bartsch H., Fluchter S-B., Atlanasio A., Gupta D. Evidence for modulation of melatonin secretion in men with benign and malignant tumours of the prostate. J. Pineal Res. 1985; 2: 121
   PubMed Web of Science ®Google Scholar
• Cohen M., Lippman M., Chabner B. The role of pineal gland in aetiology and treatment of breast cancer. Lancet 1978; 2: 814
   PubMed Web of Science ®Google Scholar
• Hamilton T. Influence of environmental light and melatonin upon mammary tumours induction. Br. J. Surg. 1969; 56: 764
   PubMed Web of Science ®Google Scholar
• Tapp E. Pineal weight in breast cancer. J. Neural Transm. 1978; 13: 399, (Suppl.)
   Google Scholar
• King R. J. B., Hayward J. L., Masters J. R. W., Willis R. R., Rubens R. D. Steroid receptor assays as prognostic aids in the treatment of breast cancer. Steroid Receptors and Hormone Dependent Neoplasia, J. L. Wittliff, O. Dapunt. Masson, New York 1980; 249
   Google Scholar
• Silman R. E., Leone R. N., Hooper R. J., Preece M. A. Melatonin, the pineal gland and puberty. Nature (London) 1979; 282: 301
   PubMed Web of Science ®Google Scholar
• Danforth D. N., Tamarkin L., Lippman M. E. Melatonin increases oestrogen receptor binding activity of human breast cancer cells. Nature (London) 1983; 305: 323
   PubMed Web of Science ®Google Scholar
• Susuzki J., Iwabuchi T. Surgical removal of pineal tumours, experience in a series of nineteen cases. J. Neurosurg. 1965; 23: 565
   PubMed Web of Science ®Google Scholar
• De Girolami U. Pathology of tumours of the pineal region. Pineal Tumours, H. H. Schmidek. Masson, New York 1977; 7
   Google Scholar
• Sweet W. H. A review of dermoid, teratoid and teratomatous intracranial tumours. Dis. Nerv. Syst. 1940; 1: 228
   Google Scholar
• Rubinstein L. J. Cytogenesis and differentiation of primitive central neuroepithelial tumours. J. Neu-ropathol. Exp. Neurol. 1972; 31: 7
   PubMed Web of Science ®Google Scholar
• Cummins F. M., Taveras J. M., Schlesinger E. B. Treatment of gliomas of the third ventricle and pinealomas with special reference to the value of radiotherapy. Neurology 1960; 10: 1031
   PubMed Web of Science ®Google Scholar
• Sklar C. A., Conte F. A., Kaplan S. L., Grumbach N. M. Human chorionic gonadotrophin secreting pineal tumour: relation to pathogenesis and sex limitation of sexual precocity. J. Clin. Endocrinol. Metab. 1981; 53: 656
   PubMed Web of Science ®Google Scholar
• Preslock J. P. The pineal gland: basic implications and clinical correlations. Endocrinol. Rev. 1984; 5: 282
   PubMed Web of Science ®Google Scholar
• Stringer J. Diabetes insipidus associated with pinealoma transplant in the tuber cinereum. Yale J. Biol. Med. 1934; 6: 375
   PubMedGoogle Scholar
• Puschett J. B., Goldberg M. Endocrinopathy associated with pineal tumour. Ann. Int. Med. 1968; 69: 203
   PubMed Web of Science ®Google Scholar
• Barber S. G., Smith J. A., Cove D. R., Smith S. C. H., London D. R. Marker for pineal tumours. Lancet 1978; 2: 372
   PubMed Web of Science ®Google Scholar
• Kennaway D. J., McCulloch G., Mathews C. D., Seamark R. F. Plasma melatonin, LH, FSH, prolactin and corticoids in two patients with pinealoma. J. Clin. Endocrinol. Metab. 1979; 49: 144
   PubMed Web of Science ®Google Scholar
• Tapp E. Melatonin as a tumour marker in pinealoma. Br Med. J. 1978; 2: 636
   Google Scholar
• Arendt J. Melatonin as a rumour marker in a patient with pinealoma. Br. Med. J. 1978; 2: 635
   Google Scholar
• Quay W. B. Experimental and spontaneous pineal tumours: findings relating to endocrine and oncogenic factors and mechanisms. J. Neural Transm. 1980; 48: 9
   PubMed Web of Science ®Google Scholar
• Miles A., Tidmarsh S. F., Philbrick D. R. S., Shaw D. M. Diagnostic potential of melatonin analyses in pineal tumour. N. Engl. J. Med. 1985; 313: 329
   PubMed Web of Science ®Google Scholar
• Svet-Moldavsky G. J., Veskova T. K., Slavina E. G., Bychkov M. B., Perevodchikova N. I., Lichynitser M. R., Trapeznikov N. N. Melatonin administration in patients with malignant melanoma. Biomedicine 1976; 25: 7
   PubMedGoogle Scholar
• Mori W. Melatonin in non-endocrinological pathology. Melatonin: Current Status and Perspectives, N. Birau, W. Schloot. Pergamon Press, New York 1981; Vol. 29, Advances in the Biosciences, Vol. 29, 349.
   Google Scholar
• Labunets I. F., Grinevich I. A., Knysh I. T., Vasiliuk A. N. Functional characteristics of the endocrine glands in skin melanoma patients. Vopr. Onkol. 1984; 30: 14
   PubMedGoogle Scholar
• Becker W. J. Epiglandol bei Dementia Praecox. Ther. Halbmonatsh. 1920; 34: 667
   Google Scholar
• Miles A., Philbrick D. R. S. Melatonin and psychiatry, a review. Biol. Psychiat.
   Google Scholar
• Parfitt A., Klein D. C. Increase caused by desmethylimipramine in the production of 3H-melatonin by isolated pineal glands. Biochem. Pharmacol 1977; 26: 904
   PubMed Web of Science ®Google Scholar
• Frazer A., Hess M., Menders J., Gable B., Kunkel E., Bender A. Influence of acute and chronic treatment with desmethylimipramine on catecholamine effects in the rat. J. Pharmacol. Exp. Ther. 1978; 206: 311
   PubMed Web of Science ®Google Scholar
• Moyer J. A., Greenberg L. H., Frazer A., Brunswick D. J., Mendels J., Weiss B. Opposite effects of acute and repeated administration of desmethylimipramine on adrenergic responsiveness in rat pineal gland. Life Sci. 1979; 24: 2237
   PubMed Web of Science ®Google Scholar
• Moyer J. A., Greenberg L. H., Frazer A., Weiss B. Subsensitivity of the beta-adrenergic receptor linked adenylate cyclase system of rat pineal gland following repeated treatment with desmethylimipramine and nialamide. Mol. Pharmacol. 1981; 19: 187
   PubMed Web of Science ®Google Scholar
• Heydorn W., Mendels J., Frazer A. Effects of darkness and of dismethylimipramine on pineal gland concentration of adenosine, 3,5-monophosphate. Biochem. Pharmacol. 1979; 29: 1341
   Web of Science ®Google Scholar
• Heydorn W., Frazer A., Mendels J. Do tricyclic antidepressants enhance adrenergic transmission? An update. Am. J. Psychiatr. 1980; 137: 113
   PubMed Web of Science ®Google Scholar
• Thompson C., Mezey G., Corn T., Franey C., English J., Arendt J., Checkley S. A. The effect of desipramine upon melatonin and Cortisol secretion in depressed and normal subjects. Br. J. Psychiatr. 1985; 147: 389
   PubMed Web of Science ®Google Scholar
• Sack R. L., Lewy A. J. Desmethylimipramine treatment increases melatonin production in humans. Biol. Psychiatr. 1986; 21: 406
   PubMed Web of Science ®Google Scholar
• Golden R. N., Markey S. P., Potter W. S. A new marker for noradrenergic function in man?. paper presented at the American Psychiatric Association Annual Meeting. Los Angeles, Calif. 1985
   Google Scholar
• Cowen P. J., Green A. R., Graham-Smith D. G., Braddock L. E. Plasma melatonin during desmethylimipramine treatment: evidence for changes in noradrenergic transmission. Br. J. Clin. Pharmacol. 1985; 19: 799
   PubMed Web of Science ®Google Scholar
• Mendlewicz J., Branchey L., Weinberg U., Branchey M., Linkowski P., Weitzman E. D. The 24-hour pattern of plasma melatonin in depressed patients before and after treatment. Commun. Psychopharmacol. 1980; 4: 49
   PubMedGoogle Scholar
• Brown R. P., Caroff S., Kocsis J. H., Amsterdam J., Winokur A., Stokes P., Frazer A. Nocturnal serum melatonin in major depressive disorder before and after desmethylimipramine treatment. Psychopharmacol. Bull. 1985; 21: 579
   PubMedGoogle Scholar
• Halbreich U., Weinberg U., Stewart J., Klein D. F., Weitzman E. D., Quitkin F. M. An inverse correlation between serum levels of desmethylimipramine and melatonin-like immunoreactivity in DMI-responsive depressives. Psychiatry Res. 1981; 4: 109
   PubMed Web of Science ®Google Scholar
• Hallonquist J. D., Goldberg M. A., Brandes J. S. Orcadian rhythms and affective disorders. Can. J. Psychiatry 1986; 31: 259
   PubMed Web of Science ®Google Scholar
• Nair N. P. V., Hariharasubramanian N., Pilapil C. Orcadian rhythm of plasma melatonin and Cortisol in endogenous depression. The Pineal Gland: Endocrine Aspects, G. M. Brown, S. D. Wainwright. Advances in the Biosciences, Pergamon Press, New York 1985; Vol. 53: 339
   Google Scholar
• Rosenthal N. E., Sack D. A., James S. H., Barbara L. P., Mendelson W. B., Tamarkin L., Wehr T. A. Seasonal affective disorder and phototherapy. Ann. N.Y. Acad. Sci. 1986; 453: 260
   Web of Science ®Google Scholar
• Lewy A. J., Goodwin F. K., Newsome D., Rosenthal N. E. Manic-depressive patients may be supersensitive to light. Lancet 1981; 1: 383
   PubMed Web of Science ®Google Scholar
• Lewy A. J. Effect of light on human melatonin production and the human circadian system. Prog. Neuropsychopharmacol. Biol. Psychiatr. 1983; 7: 551
   PubMed Web of Science ®Google Scholar
• Lewy A. J. Human melatonin secretion, a marker for the circadian system and the effects of light. Neurobiology of Mood Disorders, R. N. Post, J. C. Ballender. Williams & Wilkins, Baltimore 1984; 215
   Google Scholar
• Lewy A. J., Kern H. A., Rosenthal N. E., Wehr T. A. Bright artificial light treatment of a manic-depressive patient with a seasonal mood cycle. Am. J. Psychiatr. 1982; 139: 1496
   PubMed Web of Science ®Google Scholar
• Kripke D. F. Photoperiodic mechanisms for depression and its treatment. Biological Psychiatry, C. Penis, G. Struwe, B. Jansson. Elsevier, Amsterdam 1981; 1249
   Google Scholar
• Kripke D. F., Rischs C., Janovwsky D. Bright white light alleviates depression. Psychiatry Res. 1983; 10: 105
   PubMed Web of Science ®Google Scholar
• Kripke D. F. The therapeutic effect of bright light in depressive patients. Ann. N.Y. Acad. Sci. 1986; 453: 270
   Google Scholar
• Seggie J., Werstiuk E. S. Lithium and melatonin rhythms: implications for depression. The Pineal Gland: Endocrine Aspects, G. M. Brown, S. D. Wainwright. Advances in the Biosciences, Pergamon Press, New York 1985; Vol. 53: 333
   Google Scholar
• Beck-Friis J., Kjellman B. F., Aperia B., linden F., Von Rosen D., Ljunggren J. G., Wetterberg L. Serum melatonin in relation to clinical variables in patients with major depressive disorders. An hypothesis of low melatonin syndrome. Acta Psychiair. Scand 1986; 71: 319
   Web of Science ®Google Scholar
• Jimerson D. C., Lynch H. J., Post R. M. Urinary melatonin rhythms during sleep deprivation in depressed patients and normals. Life Sci. 1977; 20: 1501
   PubMed Web of Science ®Google Scholar
• Lewy A. J., Wehr T. A., Gold P. W., Goodwin F. K. Plasma melatonin and manic-depressive illness. Catecholamines, Basic and Clinical Frontiers, E. Usdin, I. J. Kopin, J. Barchas. Pergamon Press, New York 1979; Vol. 2, Vol. 2, 1173
   Google Scholar
• Wetterberg L., Aperia B., Beck-Friis J., Kjellman B. F., Ljunggren J. G., Petterson U., Sjolin A., Tham A. Pineal-hypothalamic-pituitary-function in patients with depressive illness. Steroid Hormone Regulation of the Brain, K. Fuxe, J. A. Gustaffson, L. Wetterberg. Pergamon Press, Oxford 1981; 397
   Google Scholar
• Mendlewicz J., Linkowski P., Branchey L. Abnormal 24-hour pattern of melatonin secretion in depression. Lancet 1979; 2: 1362
   PubMed Web of Science ®Google Scholar
• Beck-Friis J., Aperia B., Kjellman B. F., Ljunggren J. G., Bilsonne A., Petterson U., Tham A., Unden F., Wetterberg L. Hormonal changes in acute depression. Biological Psychiatry, C. Penis, G. Struwe, B. Jansson. Elsevier/North Holland, Amsterdam 1981; 1244
   Google Scholar
• Wetterberg L., Beck-Friis J., Aperia B., Kjellman B. F., Ljunggren J. G., Petterson U., Sjolin A. Melatonin-Cortisol ratio in depression. Lancet. 1979; 2: 1361
   Web of Science ®Google Scholar
• Wirz-Justice A., Arendt J. Diurnal, menstrual cycle and seasonal rhythms in man and their modification. Biological Psychiatry Today, J. Obiols, G. Ballus, E. Gonzales-Monclus. Elsevier/ North Holland, Amsterdam 1979; 294
   Google Scholar
• Claustrat B., Chazot G., Brun J., Jordon D., Sassolas G. A chronobiological study of melatonin and Cortisol secretion in depressed subjects; plasma melatonin, a biochemical marker in major depression. Biol. Psychiatr. 1984; 19: 1215
   PubMed Web of Science ®Google Scholar
• Brown R. P., Kocsis J. H., CarofT S., Amsterdam J., Winokur A., Stokes P. E., Frazer A. Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am. J. Psychiatr. 1985; 142: 811
   PubMed Web of Science ®Google Scholar
• Boyce P. M. 6-Sulphatoxymelatonin in melancholia. Am. J. Psychiatr. 1985; 142: 125
   PubMed Web of Science ®Google Scholar
• Wetterberg L., Aperia B., Beck-Friis J., Kjellman B. F., Ljunggren J. G., Nilsonne A., Petterson U., Tham A., Unden F. Melatonin and Cortisol levels in psychiatric illness. Lancet 1982; 2: 100
   PubMed Web of Science ®Google Scholar
• Wetterberg L. The relationship between the pineal gland and the pituitary-adrenal axis in healthy, endocrine and psychiatric conditions. Psychoneuroendocrinology 1983; 8: 75
   PubMed Web of Science ®Google Scholar
• Wetterberg L., Beck-Friis J., Kjellman B. F., Ljunggren J. G. Orcadian rhythms in melatonin and Cortisol secretion in depression. Frontiers in Biochemical and Pharmacological Research in Depression, E. Usdin, M. Asberg, L. Bertilsson, F. Sjoqvist. Raven Press, New York 1984; 197
   Google Scholar
• Steiner M., Brown G. M. Melatonin-Cortisol ratio and the dexamethasone suppression test in newly admitted psychiatric inpatients. The Pineal Gland, Endocrine Aspects, G. M. Brown, S. D. Wainwright. Advances in the Biosciences, Pergamon Press, New York 1985; Vol. 53: 347
   Google Scholar
• Ferrier I. N., Johnstone E. C., Crow I. J., Arendt J. Melatonin-Cortisol ratio in psychiatric illness. Lancet 1982; 1: 1070
   PubMed Web of Science ®Google Scholar
• Ferrier I. N., Arendt J., Johnstone E. C., Crow T. J. Reduced nocturnal secretion of melatonin in chronic schizophrenia; relationship to body weight. Clin. Endocrinol. 1982; 17: 181
   PubMed Web of Science ®Google Scholar
• Wire-Justice A., Arendt J. Plasma melatonin and antidepressant drugs. Lancet 1980; 1: 425
   Web of Science ®Google Scholar
• McLsaac W. M. A biochemical concept of mental disease. Postgrad. Med. 1961; 30: 111
   PubMed Web of Science ®Google Scholar
• Smythies J. R. Recent progress in schizophrenia research. Lancet 1976; 2: 136
   PubMed Web of Science ®Google Scholar
• Hartley R., Smith J. A. The activation of pineal HIOMT by psychotomimetic drugs. J. Pharm. Pharmacol 1973; 25: 751
   PubMed Web of Science ®Google Scholar
• Owen F., Ferrier I. N., Poulter M. HIOMT activity in human pineals; a comparison of controls and schizophrenics. Clin. Endocrinol. 1983; 19: 313
   PubMed Web of Science ®Google Scholar
• Hanssen T., Heydorn T., Sundberg J., Alfredsson G., Nyback H., Wetterberg L. Propranolol in schizophrenia: clinical, metabolic and pharmacological findings. Arch. Gen. Psychiatr. 1980; 37: 685
   PubMed Web of Science ®Google Scholar
• Beckmann H., Wetterberg L., Gattaz W. F. Melatonin immunoreactivity in the cerebrospinal fluid of schizophrenic patients and healthy controls. Psychiatry Res. 1984; 11: 107
   PubMed Web of Science ®Google Scholar